The Framingham Heart Study's Impact on Global Risk Assessment
- 31 August 2010
- journal article
- review article
- Published by Elsevier BV in Progress in Cardiovascular Diseases
- Vol. 53 (1), 68-78
- https://doi.org/10.1016/j.pcad.2010.04.001
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- C-Reactive Protein and Parental History Improve Global Cardiovascular Risk PredictionCirculation, 2008
- Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2BMJ, 2008
- Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohortThe Lancet, 2008
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort studyBMJ, 2007
- Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)Heart, 2005
- Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseasesNutrition, Metabolism and Cardiovascular Diseases, 2005
- Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IVJournal of Human Hypertension, 2004
- Probability of stroke: a risk profile from the Framingham Study.Stroke, 1991
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991